Document Detail


Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
MedLine Citation:
PMID:  17353299     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Our goal was to determine trends in low birth weight and preterm birth among US infants born to HIV-infected women. METHODS: We used data from the longitudinal Pediatric Spectrum of HIV Disease, a large HIV cohort, to assess trends in low birth weight and preterm birth from 1989 to 2004 among 11,321 study infants. Among women with prenatal care, we also assessed risk factors, including maternal antiretroviral therapy during pregnancy, that were predictive of low birth weight and preterm birth using univariate and multivariate logistic regression models. RESULTS: Overall, 11,231 of 14,464 infants who were enrolled in Pediatric Spectrum of HIV Disease were tested during the neonatal period. From 1989 to 2004, testing increased from 32% to 97%. The proportion of HIV-exposed infants who had low birth weight decreased from 35% to 21% and occurred in all racial/ethnic groups. Prevalence of preterm birth decreased from 35% to 22% and occurred in all groups. Any maternal antiretroviral therapy use increased from 2% to 84%. Among 8793 women who had prenatal care, low birth weight was associated with a history of illicit maternal drug use, unknown maternal HIV status before delivery, symptomatic maternal HIV disease, black race, Hispanic ethnicity, and infant HIV infection. Antiretroviral therapy or lack of it was not associated with low birth weight. Among women with prenatal care, preterm birth was associated with a history of illicit maternal drug use, symptomatic maternal HIV disease, no antiretroviral therapy, receipt of a 3-drug highly active antiretroviral therapy regimen with protease inhibitors, black race, and infant HIV infection. CONCLUSIONS: The proportion of infants who had low birth weight or were born preterm declined during an era of increased maternal antiretroviral therapies. These Pediatric Spectrum of HIV Disease trends differ from the overall increases in both outcomes among the US population.
Authors:
Joann Schulte; Ken Dominguez; Thomas Sukalac; Beverly Bohannon; Mary Glenn Fowler;
Related Documents :
15933559 - Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zido...
11476529 - Evaluation of a regional pilot program to prevent mother-infant hiv transmission--thail...
24614369 - Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried bl...
23935289 - Different fatty acid composition of serum phospholipids of small and appropriate for ge...
23181499 - Hepatoblastoma in an infant with paternal uniparental disomy 14.
23679669 - Hyperglycemia as a risk factor for the development of retinopathy of prematurity.
15933559 - Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zido...
10807229 - Inguinal hernia in infants with very low birth weight.
20476509 - Evaluation and management of apparent life-threatening events in infants.
Publication Detail:
Type:  Journal Article     Date:  2007-03-12
Journal Detail:
Title:  Pediatrics     Volume:  119     ISSN:  1098-4275     ISO Abbreviation:  Pediatrics     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-04-03     Completed Date:  2007-04-23     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e900-6     Citation Subset:  AIM; IM    
Affiliation:
Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. jzs1@cdc.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analysis of Variance
Anti-Retroviral Agents / therapeutic use
Antiretroviral Therapy, Highly Active / methods*
Centers for Disease Control and Prevention (U.S.)
Cohort Studies
Confidence Intervals
Female
Follow-Up Studies
Gestational Age
HIV Infections / diagnosis,  drug therapy*,  transmission
Humans
Incidence
Infant
Infant, Low Birth Weight*
Infant, Newborn
Infant, Premature*
Infectious Disease Transmission, Vertical / prevention & control
Logistic Models
Male
Maternal Welfare
Odds Ratio
Pregnancy
Pregnancy Complications, Infectious / diagnosis,  drug therapy*
Pregnancy Outcome
Registries
Risk Assessment
Treatment Outcome
United States
Chemical
Reg. No./Substance:
0/Anti-Retroviral Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence i...
Next Document:  Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome: a case series.